Status:
COMPLETED
Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum
Lead Sponsor:
Ankara Etlik City Hospital
Conditions:
Hyperemesis Gravidarum
Pregnant With Complication
Eligibility:
FEMALE
21-35 years
Brief Summary
In this study, the investigators planned to investigate maternal serum pepsinogen-1 (MSPG-1) levels in pregnant women with severe hyperemesis gravidarum (HG) and pregnant women without severe HG. HG ...
Detailed Description
The study will enroll pregnant women in the first trimester with maternal age between 21 and 35 years who were diagnosed with hyperemesis gravidarum and had no fetal congenital or chromosomal abnormal...
Eligibility Criteria
Inclusion
- A singleton pregnancy
- Between 21 and 35 years old
- Diagnosis of hyperemesis gravidarum
Exclusion
- Multiple pregnancy
- Fetal congenital and chromosomal abnormalities
- Chronic drug use, alcohol and smoking
- Pregnant women with diabetes or obesity, peptic ulcer or gastritis, liver and/or gallbladder disease (cholangitis or gallstones), thyroid dysfunction, urinary tract infection, celiac disease, cardiovascular or renal disease
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 21 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06581796
Start Date
July 1 2024
End Date
November 21 2024
Last Update
November 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)